Pompe Disease: A Review of the Current Diagnosis and Treatment Recommendations in the Era of Enzyme Replacement Therapy
Authors:
- Lara W KatzinLKLara W Katzin
- Anthony A AmatoAAAnthony A Amato
- 1 June 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Clinical Neuromuscular Disease
- Vol. 9 (4) , 421-431
Abstract
Pompe disease, or glycogen storage disease type II, is a rare autosomal recessive disorder caused by mutations in the gene that encodes for α-glucosidase. Presentation in infancy is associated with respiratory failure, cardiomyopathy, and severe muscle weakness. Juvenile- or adult-onset cases typically present with proximal muscle weakness and are associated with respiratory insufficiency or exertional dyspnea. Treatment, until recently, was focused on supportive measures, and infants diagnosed with Pompe disease usually died within the first year of life. The recent development of recombinant α-glucosidase has dramatically improved the life expectancy and quality of life of infantile-onset disease with improvements in respiratory and motor function observed in juvenile- or adult-onset cases. This review focuses on the presentation, pathogenesis, diagnosis, and treatment recommendations for Pompe disease in this new era of enzyme replacement therapy.Keywords
This publication has 46 references indexed in Scilit:
- Fatigue: an important feature of late-onset Pompe diseaseJournal of Neurology, 2007
- Autophagy and Mistargeting of Therapeutic Enzyme in Skeletal Muscle in Pompe DiseaseMolecular Therapy, 2006
- Ambulatory electrocardiogram analysis in infants treated with recombinant human acid α-glucosidase enzyme replacement therapy for Pompe diseaseGenetics in Medicine, 2006
- Pompe disease diagnosis and management guidelineGenetics in Medicine, 2006
- Effects of non-contractile inclusions on mechanical performance of skeletal muscleJournal of Biomechanics, 2005
- Pompe disease in infants and childrenThe Journal of Pediatrics, 2004
- Development of a disease-specific disability instrument for Pompe diseasePediatric Rehabilitation, 2003
- Consensus Conference SummaryAmerican Journal of Physical Medicine & Rehabilitation, 2002
- Pompe's disease in Chinese and prenatal diagnosis by determination of α‐glucosidase activityJournal of Inherited Metabolic Disease, 1986
- Pompe's disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndromeAmerican Heart Journal, 1978